Apnimed, Inc. Common Stock APMD
$26.22
-9.59%
at last close
Analyst Consensus
- Consensus Rating
- Buy (4 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $50.33
- Implied Upside
- +92.0%
- Price Target Range
- $41.00 – $60.00
- Analysts (12 mo)
- 4
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-25 | LifeSci CapitalFrancois Brisebois |
Initiates coverage on | Outperform | $50 |
| 2026-08-25 | Cantor FitzgeraldJosh Schimmer |
Initiates coverage on | Overweight | $60 |
| 2026-08-25 | Evercore ISI GroupUmer Raffat |
Initiates coverage on | Outperform | — |
| 2026-08-25 | B of A SecuritiesJason Gerberry |
Initiates coverage on | Buy | $41 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $26.22
- Market Cap
- $1.09 billion
- 52-Week Range
- $16.12 – $35.29
- Average Volume
- 491K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.